These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22343518)

  • 1. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.
    Cao X; Fu M; Wang L; Liu H; Deng W; Qu R; Su W; Wei Y; Xu X; Yu J
    Acta Biomater; 2012 Jul; 8(6):2104-12. PubMed ID: 22343518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs.
    Cao X; Deng W; Fu M; Zhu Y; Liu H; Wang L; Zeng J; Wei Y; Xu X; Yu J
    Eur J Pharm Sci; 2013 Jan; 48(1-2):64-71. PubMed ID: 23123331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.
    Shangguan M; Lu Y; Qi J; Han J; Tian Z; Xie Y; Hu F; Yuan H; Wu W
    J Biomater Appl; 2014 Feb; 28(6):887-96. PubMed ID: 24008629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
    Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J; Hou SX; Feng JF; Cai BQ
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
    Wu W; Wang Y; Que L
    Eur J Pharm Biopharm; 2006 Jul; 63(3):288-94. PubMed ID: 16527467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Characterization of Silymarin Synchronized and Sustained Release Dropping Pill.
    Liu ZH; Li XJ; Huang AW; Zhang J; Song HT
    Curr Drug Deliv; 2017; 14(5):650-657. PubMed ID: 28201965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.
    Yang KY; Hwang du H; Yousaf AM; Kim DW; Shin YJ; Bae ON; Kim YI; Kim JO; Yong CS; Choi HG
    Int J Nanomedicine; 2013; 8():3333-43. PubMed ID: 24039417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity.
    Hwang du H; Kim YI; Cho KH; Poudel BK; Choi JY; Kim DW; Shin YJ; Bae ON; Yousaf AM; Yong CS; Kim JO; Choi HG
    J Microencapsul; 2014; 31(7):619-26. PubMed ID: 24766208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing bioavailability of silymarin.
    Javed S; Kohli K; Ali M
    Altern Med Rev; 2011 Sep; 16(3):239-49. PubMed ID: 21951025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
    Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
    Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
    Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure.
    Shangguan M; Qi J; Lu Y; Wu W
    Int J Pharm; 2015 Jul; 489(1-2):195-202. PubMed ID: 25956049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.